Corline Biomedical to exhibit at MD&M Midwest trade show

• Corline Biomedical will exhibit at the MD&M Midwest medical technology trade show in Minneapolis on Oct. 28-29, 2026.
• Attendance supports the company’s CHS Growth Initiative, targeting expanded US commercial traction for its CHS antithrombotic surface technology.
• Focus areas include advanced catheters, structural heart, neurovascular, peripheral vascular applications.
• US positioning strengthened following FDA clearance in September 2025 for Kardium’s Globe Pulsed Field System using CHS in the catheter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corline Biomedical AB published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280453OMX_____CNEWS_SV_GNW1001274895_sv) on September 28, 2026, and is solely responsible for the information contained therein.